Skip to main content
Premium Trial:

Request an Annual Quote

GeneGo Licenses Pathways Software to Invitrogen

NEW YORK, June 1 (GenomeWeb News) - GeneGo has licensed its pathways database and software system to Invitrogen, the companies said today.

 

The multi-year licensing agreement includes plans for a collaboration to develop new capabilities for the software. The companies did not disclose the financial details of the agreement.

 

Michael Stapleton, general manager and vice president of Invitrogen's bioinformatics business, said in a statement that the licensing deal would "help us in making bioinformatics an intrinsic part of Invitrogen's solutions set for life science research."

 

GeneGo, of St. Joseph, Mich., has developed a program, MetaCore, that includes a database of molecular cellular pathways and is designed to integrate data from different levels of cellular function, including membrane receptors, signal transduction, transcription factors, and effector networks. The target users are pharmaceutical scientists engaged in target selection and validation, biomarker identification, and toxicology, the company said.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.